Accendra shareholders elect six directors, ratify KPMG, approve 2023 incentive plan amendment

ACCENDRA HEALTH INC/VA/

All six director nominees elected with votes for ranging from 48.8M to 51.2M; broker non-votes 9.8M.
KPMG ratified as auditor for FY 2026 with 61.3M for, 0.7M against.
Advisory say-on-pay passed with 48.1M for, 4.1M against (excluding 9.8M broker non-votes).
Amended and restated 2023 Omnibus Incentive Plan approved with 50.6M for, 1.6M against.
Approximately 81.3% of outstanding shares voted at the meeting.

item 5.02item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.